Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0186 | 0.9015 | 1 |
Echinococcus multilocularis | Metazoa galactosyltransferase | 0.0053 | 0.2052 | 0.2276 |
Schistosoma mansoni | DNA polymerase alpha catalytic subunit | 0.0045 | 0.162 | 0.1797 |
Trypanosoma cruzi | thymidine kinase, putative | 0.0205 | 1 | 1 |
Echinococcus multilocularis | thymidylate synthase | 0.0186 | 0.9015 | 1 |
Echinococcus multilocularis | Ribosomal protein L34a | 0.0039 | 0.1321 | 0.1465 |
Schistosoma mansoni | beta-14-galactosyltransferase | 0.0053 | 0.2052 | 0.2276 |
Echinococcus multilocularis | DNA polymerase alpha catalytic subunit | 0.0045 | 0.162 | 0.1797 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0186 | 0.9015 | 0.8985 |
Schistosoma mansoni | beta-14-galactosyltransferase | 0.0053 | 0.2052 | 0.2276 |
Trypanosoma brucei | thymidine kinase | 0.0205 | 1 | 1 |
Echinococcus granulosus | Ribosomal protein L34a | 0.0039 | 0.1321 | 0.1465 |
Toxoplasma gondii | DNA polymerase (pol2) superfamily protein | 0.0036 | 0.1176 | 0.1304 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0186 | 0.9015 | 0.8985 |
Brugia malayi | Galactosyltransferase family protein | 0.0053 | 0.2052 | 0.2276 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0205 | 1 | 1 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0186 | 0.9015 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.25 | 0.2773 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0205 | 1 | 1 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0186 | 0.9015 | 0.5 |
Echinococcus granulosus | Metazoa galactosyltransferase | 0.0053 | 0.2052 | 0.2276 |
Brugia malayi | thymidylate synthase | 0.0186 | 0.9015 | 1 |
Mycobacterium ulcerans | thymidylate synthase | 0.0186 | 0.9015 | 0.5 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0088 | 0.3906 | 0.372 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0186 | 0.9015 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0088 | 0.3906 | 0.372 |
Echinococcus granulosus | DNA polymerase alpha catalytic subunit | 0.0045 | 0.162 | 0.1797 |
Brugia malayi | DNA polymerase alpha catalytic subunit | 0.0036 | 0.1176 | 0.1304 |
Loa Loa (eye worm) | thymidylate synthase | 0.0186 | 0.9015 | 1 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0186 | 0.9015 | 1 |
Trypanosoma cruzi | thymidine kinase, putative | 0.0205 | 1 | 1 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0186 | 0.9015 | 0.8985 |
Trypanosoma brucei | RNA helicase, putative | 0.0113 | 0.5203 | 0.5057 |
Echinococcus multilocularis | Metazoa galactosyltransferase | 0.0045 | 0.162 | 0.1797 |
Schistosoma mansoni | hypothetical protein | 0.0113 | 0.5203 | 0.5771 |
Brugia malayi | hypothetical protein | 0.0088 | 0.3906 | 0.4332 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0186 | 0.9015 | 1 |
Onchocerca volvulus | 0.0186 | 0.9015 | 1 | |
Schistosoma mansoni | DNA polymerase alpha catalytic subunit | 0.0017 | 0.015 | 0.0166 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0205 | 1 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.013 | 0.6071 | 0.4239 |
Leishmania major | thymidine kinase, putative | 0.0205 | 1 | 1 |
Loa Loa (eye worm) | galactosyltransferase | 0.0053 | 0.2052 | 0.2276 |
Echinococcus granulosus | thymidylate synthase | 0.0186 | 0.9015 | 1 |
Giardia lamblia | Thymidine kinase | 0.0205 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.